Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2022-05-25 2022-05-25
Drug Identification Number 02320312 02320312
Brand name SANDOZ METHYLPHENIDATE SR SANDOZ METHYLPHENIDATE SR
Common or Proper name METHYLPHENIDATE METHYLPHENIDATE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100PRT BO 100PRT BO
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-05-24 2022-05-24
Remaining supply date 2022-05-24 2022-05-24
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments